Twist Bioscience(TWST)
$122.59-9.54 (-7.22%)
TWST
Twist Bioscience financials statements
$122.59
At close:-9.54 (-7.22%)
Want to see TWST full AI Analyst Report?
Twist Bioscience (TWST) Ratios
1,310 Followers
Twist Bioscience Ratios
TWST's free cash flow for Q3 2026 was $-8.55M. For the 2026 fiscal year, TWST's free cash flow was decreased by $-9.66M and operating cash flow was $1.11M. See a summary of the company’s cash flow.
| Ratios | Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.64 | 4.88 | 5.79 | 6.58 | 8.67 |
| Quick Ratio | 3.33 | 4.54 | 5.35 | 6.15 | 8.16 |
| Cash Ratio | 2.00 | 3.19 | 3.91 | 4.18 | 7.39 |
| Solvency Ratio | -0.31 | -1.25 | -1.15 | -1.17 | -1.17 |
| Operating Cash Flow Ratio | -0.52 | -0.90 | -1.94 | -1.37 | -1.78 |
| Short-Term Operating Cash Flow Coverage | -3.45 | 0.00 | 0.00 | 0.00 | -72.32 |
| Net Current Asset Value | $ 164.06M | $ 205.14M | $ 271.29M | $ 424.49M | $ 425.22M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.21 | 0.14 | 0.12 | 0.10 | 0.09 |
| Debt-to-Equity Ratio | 0.29 | 0.18 | 0.15 | 0.12 | 0.11 |
| Debt-to-Capital Ratio | 0.23 | 0.15 | 0.13 | 0.11 | 0.10 |
| Long-Term Debt-to-Capital Ratio | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.36 | 1.30 | 1.25 | 1.22 | 1.21 |
| Debt Service Coverage Ratio | -3.82 | -6112.59 | -35060.60 | -2515.86 | -73.99 |
| Interest Coverage Ratio | 0.00 | -7614.86 | -43431.80 | -2934.70 | -416.15 |
| Debt to Market Cap | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 2.30 | 1.47 | 1.65 | 1.76 | 1.31 |
| Net Debt to EBITDA | 0.88 | 0.80 | 1.10 | 1.34 | 2.80 |
| Profitability Margins | |||||
| Gross Profit Margin | 50.72% | 42.61% | 36.61% | 41.38% | 39.08% |
| EBIT Margin | -20.43% | -66.50% | -83.01% | -112.10% | -116.12% |
| EBITDA Margin | -13.83% | -56.46% | -71.05% | -103.99% | -108.75% |
| Operating Profit Margin | -36.18% | -70.56% | -88.60% | -115.33% | -115.41% |
| Pretax Profit Margin | -20.43% | -66.51% | -83.01% | -112.14% | -116.39% |
| Net Profit Margin | -20.63% | -66.69% | -83.48% | -107.02% | -114.94% |
| Continuous Operations Profit Margin | -20.63% | -66.69% | -83.48% | -107.02% | -114.94% |
| Net Income Per EBT | 100.93% | 100.27% | 100.57% | 95.44% | 98.75% |
| EBT Per EBIT | 56.47% | 94.26% | 93.69% | 97.23% | 100.85% |
| Return on Assets (ROA) | -12.10% | -33.98% | -26.35% | -22.66% | -21.66% |
| Return on Equity (ROE) | -16.42% | -44.16% | -32.82% | -27.60% | -26.19% |
| Return on Capital Employed (ROCE) | -24.75% | -40.64% | -30.89% | -26.96% | -23.90% |
| Return on Invested Capital (ROIC) | -24.15% | -39.57% | -30.25% | -25.34% | -23.24% |
| Return on Tangible Assets | -14.22% | -40.61% | -32.17% | -26.70% | -23.00% |
| Earnings Yield | -4.61% | -7.96% | -17.75% | -11.47% | -2.95% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.57 | 8.97 | 5.56 | 5.05 | 4.64 |
| Payables Turnover | 16.73 | 110.20 | 11.06 | 5.94 | 5.41 |
| Inventory Turnover | 6.56 | 7.46 | 4.85 | 3.04 | 2.54 |
| Fixed Asset Turnover | 2.48 | 1.94 | 1.21 | 0.95 | 1.25 |
| Asset Turnover | 0.59 | 0.51 | 0.32 | 0.21 | 0.19 |
| Working Capital Turnover Ratio | 1.46 | 1.00 | 0.57 | 0.41 | 0.34 |
| Cash Conversion Cycle | 89.42 | 86.32 | 107.93 | 131.02 | 155.26 |
| Days of Sales Outstanding | 55.56 | 40.70 | 65.62 | 72.25 | 78.74 |
| Days of Inventory Outstanding | 55.68 | 48.93 | 75.32 | 120.23 | 143.97 |
| Days of Payables Outstanding | 21.82 | 3.31 | 33.01 | 61.46 | 67.46 |
| Operating Cycle | 111.24 | 89.63 | 140.94 | 192.48 | 222.72 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.80 | -1.10 | -2.50 | -2.31 | -2.33 |
| Free Cash Flow Per Share | -1.26 | -1.19 | -2.99 | -4.20 | -2.89 |
| Dividend Paid and CapEx Coverage Ratio | -1.70 | -12.63 | -5.13 | -1.22 | -4.15 |
| Capital Expenditure Coverage Ratio | -1.70 | -12.63 | -5.13 | -1.22 | -4.15 |
| Operating Cash Flow Coverage Ratio | -0.35 | -0.75 | -1.51 | -1.31 | -1.78 |
| Operating Cash Flow to Sales Ratio | -0.13 | -0.20 | -0.58 | -0.61 | -0.85 |
| Free Cash Flow Yield | -4.49% | -2.64% | -14.77% | -11.91% | -2.70% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -21.65 | -12.56 | -5.63 | -8.72 | -33.93 |
| Price-to-Sales (P/S) Ratio | 4.47 | 8.38 | 4.70 | 9.33 | 39.00 |
| Price-to-Book (P/B) Ratio | 3.56 | 5.55 | 1.85 | 2.41 | 8.89 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -22.25 | -37.89 | -6.77 | -8.39 | -37.05 |
| Price-to-Operating Cash Flow Ratio | -35.34 | -40.90 | -8.09 | -15.27 | -45.98 |
| Price-to-Earnings Growth (PEG) Ratio | 0.34 | 0.00 | 0.52 | -0.31 | 2.88 |
| Enterprise Value Multiple | -31.43 | -14.03 | -5.51 | -7.63 | -33.07 |
| Enterprise Value | 1.64B | 2.48B | 960.09M | 1.62B | 4.76B |
| EV to EBITDA | -31.43 | -14.03 | -5.51 | -7.63 | -33.07 |
| EV to Sales | 4.35 | 7.92 | 3.92 | 7.93 | 35.96 |
| EV to Free Cash Flow | -21.65 | -35.85 | -5.64 | -7.14 | -34.16 |
| EV to Operating Cash Flow | -34.38 | -38.69 | -6.74 | -12.98 | -42.39 |
| Tangible Book Value Per Share | 6.31 | 6.42 | 8.49 | 11.95 | 11.19 |
| Shareholders’ Equity Per Share | 7.91 | 8.15 | 10.96 | 14.65 | 12.04 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | -0.00 | -0.01 | 0.05 | 0.01 |
| Revenue Per Share | 6.30 | 5.39 | 4.31 | 3.78 | 2.74 |
| Net Income Per Share | -1.30 | -3.60 | -3.60 | -4.04 | -3.15 |
| Tax Burden | 1.01 | 1.00 | 1.01 | 0.95 | 0.99 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.21 | 0.29 | 0.44 | 0.59 | 0.52 |
| SG&A to Revenue | 0.66 | 0.70 | 0.76 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.17 | 0.16 | 0.12 | 0.39 | 0.28 |
| Income Quality | 0.61 | 0.31 | 0.70 | 0.57 | 0.74 |
Currency in USD
